|  | 
 Demitri Papolos, M.D., Melissa Cockerham, 
              M.S., and John Hennen, Ph.D.
 While there is continuing debate over the validity of the diagnosis 
              of mania in children, since 1994 a number of systematic clinical 
              investigations and family/genetic studies have begun to shed light 
              on the presentation and naturalistic course of childhood-onset bipolar 
              disorder, suggesting a developmentally different presentation in 
              young children as compared to its adult form. Adult-onset and juvenile-onset 
              forms of BPD have certain similar features and comorbidities in 
              common, but in the juvenile form of the disorder, the complexities 
              wrought by the frequent overlap of symptoms with other disorders 
              that are far more commonly diagnosed in childhood has had a confounding 
              affect on clinical diagnostic practice for years. Part of the problem 
              appears to be that the co-occurring conditions, such as attention 
              deficit hyperactivity disorder ,depression, obsessive compulsive 
              disorder and conduct disorder are more easily recognizable to clinicians, 
              and far more commonly diagnosed than bipolar disorder.  A leading source of diagnostic confusion in childhood mania is 
              its symptomatic overlap with attention deficit hyperactivity disorder 
              (ADHD). Systematic studies of children and adolescents show that 
              rates of ADHD range from 60% to 90% in pediatric patients with mania. 
              Because of overlapping symptoms between current DSM-IV diagnostic 
              categories, incomplete and misleading criteria for the diagnosis 
              of childhood-onset bipolar disorder (COPD), as well as a long-standing 
              bias against the diagnosis in childhood, many individuals are commonly 
              first diagnosed with one or another of the co-occurring conditions 
              before COBPD is considered.  This diagnostic confusion can lead to significant adverse effects 
              and poor treatment outcomes, particularly when stimulants and antidepressant 
              medications are introduced in the setting of undiagnosed pediatric 
              bipolar disorder. Therefore, it is imperative that additional clinical 
              methods be developed to assist clinicians in rapidly screening individuals 
              at risk to arrive at appropriate diagnoses. Additionally, future 
              genetic studies will benefit from the development of well-validated 
              and reliable screening instruments.  The Child Bipolar Questionnaire (CBQ) has been developed to serve 
              as a screening inventory of symptoms and common behavioral features 
              of childhood-onset bipolar disorder. The first version of the questionnaire 
              contained 85 items drawn from DSM-IV categories of childhood psychiatric 
              illnesses. This inventory was constructed to score rates of symptoms 
              for specific age ranges retrospectively. 220 parents of children 
              diagnosed according to DSM-IV criteria (revised for the inclusion 
              of ultra-rapid cycling) were administered this questionnaire. The 
              most common positively endorsed symptoms and behaviors were rank 
              ordered according to frequency of occurrence and of these, the 65 
              highest rated symptoms were included in the CBQ 
              Version 2.0.   The study we propose will assess the validity and potential utility 
              of the CBQ V.2.0 as a screening instrument that can be used by pediatricians 
              and mental health practitioners, including child psychiatrists, 
              psychologists and social workers, as well as for family genetic 
              and offspring studies. We want to assess the ability of this instrument 
              to satisfy three prerequisites for use in such clinical and research 
              settings: (1) identification of core symptom categories related 
              to bipolar disorder (2) use with children and young adolescents, 
              and (3) ability to distinguish between affected and well siblings 
              and control subjects with attention-deficit disorder with hyperactivity.  The CBQ will be administered to 50 parents of children diagnosed 
              with bipolar disorder. Control subjects from a community sample 
              and subjects with attention-deficit disorder with hyperactivity 
              will constitute the comparison groups.  Diagnoses will be according to new research criteria for juvenile-onset 
              bipolar, DSM-IV (revised criteria) by blind semiuctured clinical 
              interview and the affective disorder supplement of the SADS P/L. 
              Parents will be asked to complete behavioral screening tools: Child 
              Bipolar Questionnaire (BCQ), Yale-Brown Obsessive-Compulsive Scale 
              (Y-BOCS), the Overt Aggression Scale (OAS), and the Child Behavioral 
              Check List. I am considering having my child participate 
              and would like to provide you with some basic information and to 
              have someone contact me. Partial funding has been provided by The Page Hill 
              Foundation, in honor of Jason Pyne. NEXT > Circadian 
              Rhythm - Sleep/Wake Study in Juvenile-onset Bipolar Disorder   |  |   New: Are you interested in finding 
  out if your children qualify to participate in the JBRF's research studies? 
  Learn more here. About the Child Bipolar Questionnaire (CBQ) and The Jeannie & Jeffrey Illustrated Interview for Children (J/J)  Request for the CBQ or J/J  Research Studies Context and Summary of JBRF Sponsored Research  Biological Consistency Genome-wide Association Scan Chronobiology Study Stem Cell Study Clinical Phenomenological 
  Study of Childhood-onset Bipolar Disorder Neuropsychological Testing 
  in Juvenile-onset Bipolar Disorder 
 |  |